Related Experiment Videos
Acute reactive stage proteins in gynaecologic cancers
European Journal of Gynaecological Oncology
|May 1, 1980
Summary
This study found elevated acute reactive proteins stage (ARPS) in women with gynecological cancers. Specific proteins like haptoglobin and alpha-1 antitrypsin increased with ovarian and cervical cancers, respectively.
Area of Science:
- Oncology
- Biochemistry
Background:
- Gynecological neoplasms represent a significant health concern for women.
- Acute reactive proteins stage (ARPS) are markers that can indicate inflammatory and neoplastic processes.
Purpose of the Study:
- To investigate plasmatic variations of ARPS in women diagnosed with gynecological neoplasms.
- To correlate ARPS levels with specific cancer types and clinical stages.
Main Methods:
- Blood samples were collected from 58 women aged 35-80 with cervical, endometrial, or ovarian cancer.
- Plasmatic levels of ARPS were analyzed, focusing on haptoglobin and alpha-1 antitrypsin.
- Data was correlated with tumor type and clinical staging (T0, T1, T2).
Main Results:
- A significant increase in ARPS was observed across all studied gynecological cancer patients.
- Haptoglobin levels were elevated in ovarian cancer patients.
- Alpha-1 antitrypsin levels were elevated in cervical cancer patients.
- ARPS variations were notable between T0 and T1 stages, indicating differences in localized vs. pelvis-confined tumors.
Conclusions:
- ARPS, particularly haptoglobin and alpha-1 antitrypsin, show significant alterations in gynecological cancers.
- These protein variations correlate with specific cancer types and early clinical stages.
- ARPS may serve as potential biomarkers for gynecological neoplasm detection and staging.